PharmaLex US

Confidence Beyond Compliance

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Read the eBook from subject-matter expert Gerardo Gomez, Ph.D. from regulatory consultancy PharmaLex.

https://t.co/s4sF6lzqsL

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Update:

Recently, the PharmaLex US Extended Leadership had an enriching session at @CencoraGlobal's headquarters, our esteemed parent company. This face-to-face collaboration wasn't just about catching up; it was about forging our path forward.

#Cencora

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Register for the RAPS Indiana Chapter’s webcast now for RAC credits on “Utilizing Regulatory Precedence for Decision Making” Monday Monday, 25 Sep 2023 (03:30 PM – 5:00 PM EST) featuring PharmaLexperts Renata Kover and Anusha Kesireddy.

https://t.co/eaWGrLsyXA

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Exciting News! Our recent "Optimizing Product Development" event in collaboration with PA Biotechnology Center was a resounding success thanks to all of you who attended and contributed to the insightful discussions.

[PharmaLex US @PharmaLexUS]

Introducing our latest episode of the PharmaLex Talks Podcast: "Avoiding Pitfalls with your Product Development Strategy," featuring special guest Alex Klein, Director of Development Consulting & Scientific Affairs at #PharmaLexUS

Click to listen now: https://t.co/QhE9fkIJOD

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Are you losing sleep over product development challenges? Join us for a game-changing event, proudly sponsored by PharmaLex and hosted at the PA Biotechnology Center that will put your mind at ease!

Register here: https://t.co/A7KKglweA5

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Check out this insightful article in the August issue of Pharmaphorum published by Michelle Anastasi at PharmaLex: "4 Questions to Determine the Health of Your Company's QMS (Quality Management System)."

Read the full article here: https://t.co/fqttZzxrkC

[PharmaLex US @PharmaLexUS]

#PharmalexUS // #PharmaLex has been supporting clients in analyzing Omics data since the beginning of genome-wide association studies (GWAS) in the early 2000s.

Learn more about Omics Data Science at PharmaLex here: https://t.co/tiH8RSCp5d

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Sunday, August 6 from 2:00 PM - 3:50 PM at the Metro Toronto Convention Centre, Room: CC-715B.

For detailed conference information, please visit: https://t.co/JNbgOj1MIx

#JSM2023 #DrivingDiscovery #InformingDecisions

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Unlocking Success in Regulatory Meetings: Check out Mark Lane, Ph.D.'s latest article on the "Top 10 Considerations when Meeting with Regulators."

Read the article here: https://t.co/mIznkRLHnX

#FDAMeetings #EMAMeetings #IPD

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // CHAT WITH STEPHEN SUN TO DISCUSS YOUR SAFETY ISSUE: PharmaLexpert Office Hours - Pharmacovigilance
https://t.co/ppozrMdWah

#SafetyReporting #PharmaceuticalRegulations #EURegulations #HealthTech #innovation #Healthcare #regulatory #innovationstomarket

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Join Our Satisfied Customers! Interested in experiencing the benefits of working with PharmaLex? Contact us today to discuss how we can help you achieve your goals. https://t.co/DQnh0rfQHs #PharmaLexSuccess #CustomerQuotes #PharmaLexTestimonials

[PharmaLex US @PharmaLexUS]

#PharmaLexUS is proud to announce our exceptional customer satisfaction rating! According to our recent survey, an overwhelming majority of our customers expressed their likelihood of working with us again on future projects. #PharmaLexSuccess #PharmaLexUS #CustomerSatisfaction

[PharmaLex US @PharmaLexUS]

EVENT #PharmaLexUS // Learn more about Annex 1 here, https://t.co/185jZJCebE

and about Contamination Control Strategies and Risk here, https://t.co/guI18XJjz1+

#CCS #QMS #CCRA

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // The road to drug innovation involves many steps and hurdles amid the need to meet tough regulatory efficacy and safety standards. Read the article by Michelle Anastasi on Key Steps to Avoid CMC Pitfalls.”

https://t.co/vY3ysX0Ttl

[PharmaLex US @PharmaLexUS]

On-Demand Video // In case you missed it, watch the Ask An Expert Event recording on “De-risking CMC Pitfalls” here.

https://t.co/dTlm5YysrH

The recording is interactive so you may access and download related resources from the recording under “Related Content.”

#CMC #QMC

[PharmaLex US @PharmaLexUS]

#PharmaLex // Event: Ask An Expert
We’re going LIVE up TOMORROW! Don’t miss out!

Date: June 1, 2023
Time: 10:00 AM EST / 4:00 PM CET
Register now to reserve your slot!

https://t.co/dTlm5YysrH

[PharmaLex US @PharmaLexUS]

#PharmaLexUS // Exciting News in the World of Biosimilars!

We’re excited to share some fascinating insights into the rapidly evolving field of biosimilars.

#Biosimilars #HealthcareInnovation #PatientAccess #MedicalAdvancements

https://t.co/dX7pCBIPKn

[PharmaLex US @PharmaLexUS]

Honoring our Heroes this Memorial Day! PharmaLex remembers and pays tribute to the brave men and women who made the ultimate sacrifice for our nation. Their dedication and courage will never be forgotten. Let's honor their memory and cherish the freedom they fought for.

[PharmaLex US @PharmaLexUS]

#PharmaLexUS  // Get to know more about Joshua!

Contact us for more information or visit: https://t.co/veFVdDMb99